Hochhaus A - Search Results

1

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.

Guilhot J, Baccarani M, Clark RE, Cervantes F, Guilhot F, Hochhaus A, Kulikov S, Mayer J, Petzer AL, Rosti G, Rousselot P, Saglio G, Saussele S, Simonsson B, Steegmann JL, Zaritskey A, Hehlmann R. Guilhot J, et al. Among authors: hochhaus a. Blood. 2012 Jun 21;119(25):5963-71. doi: 10.1182/blood-2011-10-383711. Epub 2012 Apr 16. Blood. 2012. PMID: 22508936 Free article.

2

[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)].

Hehlmann R, Heimpel H, Heinze B, Georgii A, Kolb HJ, Hossfeld DK, von Wussow P, Hochhaus A, Griesshammer M, Diehl V, et al. Hehlmann R, et al. Among authors: hochhaus a. Onkologie. 1991 Feb;14(1):66-73. doi: 10.1159/000216948. Onkologie. 1991. PMID: 2057176 Clinical Trial. German.

3

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.

Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, et al. Hehlmann R, et al. Among authors: hochhaus a. Blood. 1994 Dec 15;84(12):4064-77. Blood. 1994. PMID: 7994025 Free article. Clinical Trial.

4

Interferon in chronic myeloid leukemia. A workshop report.

Griesshammer M, Hehlmann R, Hochhaus A, Talpaz M, Tura S, Stryckmans P, Allan NC, Tanzer J, Kolb HJ, Heimpel H. Griesshammer M, et al. Among authors: hochhaus a. Ann Hematol. 1993 Aug;67(2):101-6. doi: 10.1007/BF01788134. Ann Hematol. 1993. PMID: 8347729 Review.

5

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Blood. 1996 Feb 15;87(4):1549-55. Blood. 1996. PMID: 8608246 Free article.

6

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC. van Rhee F, et al. Among authors: hochhaus a. Blood. 1996 Jun 15;87(12):5213-7. Blood. 1996. PMID: 8652835 Free article.

7

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Blood. 1996 Sep 15;88(6):2236-40. Blood. 1996. PMID: 8822944 Free article.

8

[Chronic myeloid leukemia. Current strategies in diagnosis, therapy and follow-up].

Hochhaus A, Hehlmann R. Hochhaus A, et al. Internist (Berl). 1996 Oct;37(10):1013-21. Internist (Berl). 1996. PMID: 9019445 Review. German. No abstract available.

9

Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia.

Hochhaus A, Yan XH, Willer A, Hehlmann R, Gordon MY, Goldman JM, Melo JV. Hochhaus A, et al. Leukemia. 1997 Jul;11(7):933-9. doi: 10.1038/sj.leu.2400723. Leukemia. 1997. PMID: 9204971

10

Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Leukemia. 1997 Apr;11 Suppl 3:541-4. Leukemia. 1997. PMID: 9209451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

683 results

Search Page